New York Presbyterian Hospital Weill Cornell
New York, New York 10021
We've found
5 trials
at this facility
Cytomegalovirus (CMV) Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
Physiologic Assessment of Coronary Stenosis Following PCI
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Antithrombin III Deficiency Clinical Trial
Updated: 2/17/2014
Safety, Pharmacokinetics and Efficacy of an AT-III Concentrate.
Status: Enrolling,
Phase
II, III
Updated: 2/17/2014
Click here to add this to my saved trials

Acute Antibody-Mediated Rejection (AMR) Clinical Trial
Updated: 12/31/1969
A Multicenter Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Participants With Kidney Transplant
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Myeloma Clinical Trial
Updated: 9/11/2015
Expanded Access Treatment Protocol CA204-143
Status: Enrolling
Updated: 9/11/2015
Click here to add this to my saved trials
